Publications by authors named "Richard Moravec"

Claim this Profile
T
Treating Cells as Reagents to Design Reproducible Assays.
Terry L Riss, Richard A Moravec, Sarah J Duellman, Andrew L Niles

SLAS Discov· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Damage Analysis of Composite CFRP Tubes Using Acoustic Emission Monitoring and Pattern Recognition Approach.
Michal Šofer, Jakub Cienciala, Martin Fusek, Pavel Pavlíček, Richard Moravec

Materials (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homogeneous, bioluminescent proteasome assays.
Martha A O'Brien, Richard A Moravec, Terry L Riss, Robert F Bulleit

Methods Mol Biol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
Zhijie Jey Cheng, Denise Garvin, Aileen Paguio, Richard Moravec, Laurie Engel

J Immunol Methods· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity testing: measuring viable cells, dead cells, and detecting mechanism of cell death.
Terry L Riss, Richard A Moravec, Andrew L Niles

Methods Mol Biol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoroscopic assessment of rotator cuff fatigue on glenohumeral arthrokinematics in shoulder impingement syndrome.
Philip J Royer, Edward J Kane, Kyle E Parks, Jacob C Morrow, Richard R Moravec

J Shoulder Elbow Surg· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening.
Andrew L Niles, Richard A Moravec, Terry L Riss

Curr Chem Genomics· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format.
Richard A Moravec, Martha A O'Brien, William J Daily, Michael A Scurria, Laurent Bernad

Anal Biochem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on in vitro cytotoxicity assays for drug development.
Andrew L Niles, Richard A Moravec, Terry L Riss

Expert Opin Drug Discov· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspase activity assays.
Andrew L Niles, Richard A Moravec, Terry L Riss

Methods Mol Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex caspase activity and cytotoxicity assays.
Andrew L Niles, Richard A Moravec, Terry L Riss

Methods Mol Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homogeneous, bioluminescent proteasome assays.
Martha A O'Brien, Richard A Moravec, Terry L Riss, Robert F Bulleit

Methods Mol Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers.
Andrew L Niles, Richard A Moravec, P Eric Hesselberth, Michael A Scurria, William J Daily

Anal Biochem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homogeneous, bioluminescent protease assays: caspase-3 as a model.
Martha A O'Brien, William J Daily, P Eric Hesselberth, Richard A Moravec, Michael A Scurria

J Biomol Screen· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays.
Terry L Riss, Richard A Moravec

Assay Drug Dev Technol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis